About Clarivate JCR-based Journal Impact Factors 2025
The Journal Impact Factor is a journal-level bibliometric indicator published by Clarivate in Journal Citation Reports (JCR). It is often abbreviated as JIF; JIF is not a separate impact factor, but simply the abbreviation for Journal Impact Factor.
The 2025 Journal Impact Factor provides a journal-level indication of citation activity. It should be interpreted within the journal’s subject area and together with other information, rather than used as a stand-alone judgment of research quality.
On this website, you can explore Journal Impact Factor records presented as Clarivate JCR-based data, together with the five-year Impact Factor, JCR quartile (Q1–Q4), JCR category rank, publisher details and journal identifiers. Verify important submission or evaluation decisions in the official Clarivate Journal Citation Reports.
Explore by research area
Browse journals by subject
Start with a broad research area, then narrow the list to a specialty or subsubject. These internal subject groups are provided for discovery and are kept separate from official Journal Citation Reports categories.
Popular specialties
Explore medical journal specialties
Browse focused journal lists within Medicine, including citation metrics, quartiles, publishers and identifiers.
Browse journal metrics
Showing records 8,811–8,820 of 20,480
| Rank | Journal | ISSN / eISSN | JCR Impact Factor | 5-Year Impact Factor | JCR Quartile | JCR Category Rank | Publisher |
|---|---|---|---|---|---|---|---|
| 8,733 |
Breast Cancer-Basic and Clinical Research BREAST CANCER-BASIC |
1178-2234 1178-2234 |
1.900 | 2.400 | Q3 | 242/326 | SAGE PUBLICATIONS LTD |
| 8,733 |
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY BRIT J ORAL MAX SURG |
0266-4356 1532-1940 |
1.900 | 1.700 | Q2 | 119/312 | CHURCHILL LIVINGSTONE |
| 8,733 |
BUILDING ACOUSTICS BUILD ACOUST |
1351-010X 2059-8025 |
1.900 | 1.600 | Q2 | 20/41 | SAGE PUBLICATIONS INC |
| 8,733 |
CALPHAD-COMPUTER COUPLING OF PHASE DIAGRAMS AND THERMOCHEMISTRY CALPHAD |
0364-5916 1873-2984 |
1.900 | 2.000 | Q2 | 44/96 | PERGAMON-ELSEVIER SCIENCE LTD |
| 8,733 |
CANADIAN JOURNAL OF CHEMICAL ENGINEERING CAN J CHEM ENG |
0008-4034 1939-019X |
1.900 | 2.200 | Q3 | 111/175 | WILEY |
| 8,733 |
Cancer Biomarkers CANCER BIOMARK |
1574-0153 1875-8592 |
1.900 | 2.000 | Q3 | 242/326 | IOS PRESS |
| 8,733 |
CANCER INVESTIGATION CANCER INVEST |
0735-7907 1532-4192 |
1.900 | 1.700 | Q3 | 242/326 | TAYLOR & FRANCIS INC |
| 8,733 |
Cancer Reports CANCER REP-US |
N/A 2573-8348 |
1.900 | 2.100 | Q3 | 242/326 | WILEY |
| 8,733 |
Cardiology Journal CARDIOL J |
1897-5593 1898-018X |
1.900 | 2.100 | Q3 | 129/230 | VIA MEDICA |
| 8,733 |
CARDIOVASCULAR PATHOLOGY CARDIOVASC PATHOL |
1054-8807 1879-1336 |
1.900 | 2.100 | Q3 | 49/90 | ELSEVIER SCIENCE INC |